Patents by Inventor Dmitry Tworowski

Dmitry Tworowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds and uses thereof in the treatment of sexual disorders
    Patent number: 9034872
    Abstract: Novel heterocyclic compounds having the Formula I: wherein A, B, D, E, G, K, L, M, Q, T, X, Y and Z are as defined herein, which exhibit a dopamine receptor (preferably a D4 receptor) agonistic activity, and/or a PDE5 inhibitory activity, processes of preparing same, pharmaceutical compositions containing same and uses thereof in the treatment of sexual disorders such as decreased libido, orgasm disorder and erectile dysfunction are disclosed.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: May 19, 2015
    Assignee: ATIR Holding S.A.
    Inventors: Dmitry Tworowski, Ron Matsievitch, Vladimir Kogan
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS
    Publication number: 20140107128
    Abstract: Novel heterocyclic compounds having the Formula I: wherein A, B, D, E, G, K, L, M, Q, T, X, Y and Z are as defined herein, which exhibit a dopamine receptor (preferably a D4 receptor) agonistic activity, and/or a PDE5 inhibitory activity, processes of preparing same, pharmaceutical compositions containing same and uses thereof in the treatment of sexual disorders such as decreased libido, orgasm disorder and erectile dysfunction are disclosed.
    Type: Application
    Filed: December 17, 2013
    Publication date: April 17, 2014
    Inventors: Dmitry TWOROWSKI, Ron Matsievitch, Vladimir Kogan
  • Heterocyclic compounds and uses thereof in the treatment of sexual disorders
    Patent number: 8614319
    Abstract: Novel heterocyclic compounds having the Formula I: wherein A, B, D, E, G, K, L, M, Q, T, X, Y and Z are as defined herein, which exhibit a dopamine receptor (preferably a D4 receptor) agonistic activity, and/or a PDE5 inhibitory activity, processes of preparing same, pharmaceutical compositions containing same and uses thereof in the treatment of sexual disorders such as decreased libido, orgasm disorder and erectile dysfunction are disclosed.
    Type: Grant
    Filed: November 13, 2012
    Date of Patent: December 24, 2013
    Assignee: ATIR Holding S.A.
    Inventors: Dmitry Tworowski, Ron Matsievitch, Vladimir Kogan
  • Heterocyclic compounds and uses thereof in the treatment of sexual disorders
    Patent number: 8349850
    Abstract: Novel heterocyclic compounds having the formula: or a pharmaceutically acceptable salt thereof, wherein A, B, D, E, G, K, L, M, Q, T, X, Y and Z are as described in the specification, which exhibit a dopamine receptor (preferably a D4 receptor) agonistic activity, and/or a PDE5 inhibitory activity, are disclosed, as well as processes of preparing same, pharmaceutical compositions containing same and uses thereof in the treatment of sexual disorders such as decreased libido, orgasm disorder and erectile dysfunction.
    Type: Grant
    Filed: March 28, 2007
    Date of Patent: January 8, 2013
    Assignee: ATIR Holding S.A.
    Inventors: Dmitry Tworowski, Ron Matsievitch, Vladimir Kogan
  • Heterocyclic Compounds And Uses Thereof In The Treatment Of Sexual Disorders
    Publication number: 20100029671
    Abstract: Novel heterocyclic compounds, which exhibit a dopamine receptor (preferably a D4 receptor) agonistic activity, and/or a PDE5 inhibitory activity, processes of preparing same, pharmaceutical compositions containing same and uses thereof in the treatment of sexual disorders such as decreased libido, orgasm disorder and erectile dysfunction are disclosed.
    Type: Application
    Filed: March 28, 2007
    Publication date: February 4, 2010
    Applicant: ATIR HOLDING S.A.
    Inventors: Dmitry Tworowski, Ron Matsievitch, Vladimir Kogan